A detailed history of James Investment Research Inc transactions in Zoetis Inc. stock. As of the latest transaction made, James Investment Research Inc holds 20,299 shares of ZTS stock, worth $3.59 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
20,299
Previous 21,126 3.91%
Holding current value
$3.59 Million
Previous $3.66 Million 8.3%
% of portfolio
0.46%
Previous 0.44%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$172.58 - $196.48 $142,723 - $162,488
-827 Reduced 3.91%
20,299 $3.97 Million
Q2 2024

Jul 30, 2024

SELL
$145.54 - $178.83 $38,859 - $47,747
-267 Reduced 1.25%
21,126 $3.66 Million
Q1 2024

May 01, 2024

SELL
$165.67 - $199.94 $46,884 - $56,583
-283 Reduced 1.31%
21,393 $3.62 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $274,863 - $363,163
1,815 Added 9.14%
21,676 $4.28 Million
Q3 2023

Oct 31, 2023

BUY
$167.14 - $192.77 $73,207 - $84,433
438 Added 2.26%
19,861 $3.46 Million
Q2 2023

Aug 07, 2023

BUY
$160.94 - $186.23 $3.13 Million - $3.62 Million
19,423 New
19,423 $3.34 Million
Q1 2023

Apr 25, 2023

BUY
$145.48 - $175.02 $244,697 - $294,383
1,682 Added 9.74%
18,945 $3.15 Million
Q4 2022

Jan 30, 2023

SELL
$131.14 - $157.47 $1.16 Million - $1.4 Million
-8,861 Reduced 33.92%
17,263 $2.53 Million
Q3 2022

Oct 31, 2022

SELL
$148.29 - $182.55 $1.11 Million - $1.36 Million
-7,467 Reduced 22.23%
26,124 $3.87 Million
Q2 2022

Aug 01, 2022

SELL
$155.97 - $200.09 $315,995 - $405,382
-2,026 Reduced 5.69%
33,591 $5.77 Million
Q1 2022

Apr 22, 2022

BUY
$181.39 - $234.03 $673,319 - $868,719
3,712 Added 11.63%
35,617 $6.72 Million
Q4 2021

Jan 28, 2022

SELL
$193.69 - $247.03 $262,256 - $334,478
-1,354 Reduced 4.07%
31,905 $7.79 Million
Q3 2021

Oct 22, 2021

SELL
$189.29 - $209.69 $100,323 - $111,135
-530 Reduced 1.57%
33,259 $6.46 Million
Q2 2021

Jul 26, 2021

SELL
$155.9 - $187.99 $3,585 - $4,323
-23 Reduced 0.07%
33,789 $6.3 Million
Q1 2021

Apr 22, 2021

BUY
$144.0 - $169.39 $74,880 - $88,082
520 Added 1.56%
33,812 $5.32 Million
Q4 2020

Jan 27, 2021

BUY
$157.07 - $174.35 $1.51 Million - $1.68 Million
9,625 Added 40.67%
33,292 $5.51 Million
Q3 2020

Oct 23, 2020

SELL
$137.1 - $165.37 $215,384 - $259,796
-1,571 Reduced 6.22%
23,667 $3.91 Million
Q2 2020

Jul 24, 2020

SELL
$111.92 - $142.53 $101,175 - $128,847
-904 Reduced 3.46%
25,238 $3.46 Million
Q1 2020

Apr 22, 2020

SELL
$92.66 - $144.94 $1.36 Million - $2.13 Million
-14,722 Reduced 36.03%
26,142 $3.08 Million
Q4 2019

Jan 24, 2020

BUY
$116.25 - $133.25 $4.01 Million - $4.6 Million
34,527 Added 544.85%
40,864 $5.41 Million
Q3 2019

Oct 30, 2019

BUY
$112.57 - $128.43 $713,356 - $813,860
6,337 New
6,337 $789,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.